- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06823011
Effects of Banned Substances on Some Metabolic Functions in Male Amateur Athletes
February 11, 2025 updated by: LEVENT CEYLAN, Hitit University
The aim of this study was to investigate the effects of banned substances on some metabolic functions in male athletes in order to raise awareness among individuals who use these substances by highlighting the potential harms of using banned substances to draw attention to the issue and raise awareness.
2) Methods: The study is a randomised cross-sectional study.
The study included 20 male amateur athletes who had actively practised bodybuilding, arm wrestling, powerlifting and weightlifting in the last 5 years and had not participated in competitions.
The study group consisted of 10 adult male amateur athletes who had used banned substances at least once a year in the past 5 years, while 10 male amateur athletes who had not used banned substances with similar qualifications formed the control group.
Participants were included in the study on a voluntary basis.
Participants' age, sports age, height, weight and BMI variables were selected and parameters related to liver, kidney, hormone and lipid profiles were determined.
The Shapiro-Wilk test was used to test the normality of the values obtained from the data.
The independent t-test was used for the data showing a normal distribution and the Mann Whitney U- test was used for the data not showing a normal distribution.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Si̇vas
-
Sivas, Si̇vas, Turkey, 58050
- Hitit Üniversity gym
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- Amateur athlete who has been actively involved in bodybuilding, arm wrestling, powerlifting and weightlifting for the last 5 years
- Adult male amateur athletes who use banned substances in at least 1 period each year
Exclusion Criteria:
- with chronic illness
- receiving continuous medication
- heavy labor
- who has recently had an infection
- amateur athletes who performed heavy exercise in the last 72 hours
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Other: group using banned substances
group doing weight training and using banned substances
|
Blood was collected from the study group and the control group at 10 am in the morning on an empty stomach.
|
|
Other: group not using banned substances
a group that does weight training but does not use banned substances
|
Blood was collected from the study group and the control group at 10 am in the morning on an empty stomach.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
body mass index BMI in Male Athletes
Time Frame: 6 months, 1 year
|
Height, body weight (BW), body mass index [BMI= BW (kg) / (height, m)2] were determined.
|
6 months, 1 year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 15, 2024
Primary Completion (Actual)
July 15, 2024
Study Completion (Actual)
August 15, 2024
Study Registration Dates
First Submitted
December 20, 2024
First Submitted That Met QC Criteria
February 11, 2025
First Posted (Actual)
March 25, 2025
Study Record Updates
Last Update Posted (Actual)
March 25, 2025
Last Update Submitted That Met QC Criteria
February 11, 2025
Last Verified
February 1, 2025
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Hitit Üniversitesi
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
The data presented in this study are available on request from the corresponding author.
The data are not publicly available due to restrictions related to ongoing work for further publications
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.